Clinical opinionObstetricsEtiology and management of postpartum hypertension-preeclampsia
Section snippets
Incidence
The exact incidence of postpartum hypertension is difficult to ascertain. In clinical practice, most women will not have their blood pressure (BP) checked until the 6 weeks' postpartum visit in physician's offices or in postpartum clinics. As a result, women with mild hypertension who are asymptomatic are usually not reported. In addition, postpartum women who have hypertension in association with symptoms such as headaches or blurred vision are often seen and managed in the emergency
Etiology and differential diagnosis
The etiology and different diagnosis of postpartum hypertension is extensive (Table), but it can be focused based on clinical and laboratory findings as well as response to treatment of BP. GH-preeclampsia (new onset or preexisting prior to delivery) is the most common cause, however, other life-threatening conditions such as pheochromocytoma and cerebrovascular accidents should also be considered.
New-onset postpartum hypertension-preeclampsia
Normal pregnancy is characterized by increased plasma volume in association with sodium and water retention in the interstitial tissue. This is further exaggerated in women with multifetal gestation. In addition, many women receive intravenously a large volume of fluids during labor, delivery, and postpartum. Large volumes of fluids are also given because of regional analgesia-anesthesia or during cesarean section. In some women, acute or delayed mobilization of large volume of fluid into the
Persistence/exacerbation of hypertension-proteinuria in women with preexisting GH-preeclampsia
Maternal hypertension and proteinuria will usually resolve during the first week postpartum in most women with GH or preeclampsia, however, there are conflicting data regarding the time it takes for resolution in such women.20, 21, 22, 23, 24, 25 The differences among various studies are due to the population studied, severity of disease process (mild, severe, with superimposed preeclampsia, HELLP syndrome), duration of follow-up, management (aggressive vs expectant), and criteria used for
Persistence/exacerbation of hypertension in chronic hypertension
Women with chronic hypertension during pregnancy are at increased risk for exacerbation of hypertension and/or superimposed preeclampsia.32 The risk depends on severity of hypertension, presence of associated medical conditions (obesity, type 2 diabetes, renal disease), or whether antihypertensive medications were used during pregnancy.32, 33 Hypertension or exacerbation of hypertension postpartum may be due to either undiagnosed essential chronic hypertension (women with limited medical care
Maternal complications
Maternal complications depend on ≥1 of the following: severity and etiology of the hypertension, maternal status at presentation (presence of organ dysfunction), and the quality of management used. Potential life-threatening complications include cerebral infarction or hemorrhage, congestive heart failure or pulmonary edema, renal failure, or death. Maternal outcome is usually good in those with only isolated hypertension or preeclampsia, whereas it is poor with pheochromocytoma,38, 39 stroke,
Evaluation and management of postpartum hypertension
Evaluation of patients with postpartum hypertension should be performed in a stepwise fashion and may require a multidisciplinary approach. Consequently, management requires a well-formulated plan that takes the following factors into consideration: predelivery risk factors, time of onset in relation to delivery, presence of signs/symptoms, results of laboratory/imaging findings, and response to initial therapy (Figure).
The most common cause for persistent hypertension beyond 48 hours after
References (52)
- et al.
Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries
Int J Gynecol Obstet
(2011) Diagnosis and management of gestational hypertension and preeclampsia
Obstet Gynecol
(2003)- et al.
The management of postpartum hypertension
BJOG
(2002) - et al.
Late postpartum eclampsia: a preventable disease?
Am J Obstet Gynecol
(2002) - et al.
Diagnosis and management of atypical preeclampsia-eclampsia
Am J Obstet Gynecol
(2009) - et al.
Emergency department use during the postpartum period: implications for current management of the puerperium
Am J Obstet Gynecol
(2010) - et al.
Delayed postpartum preeclampsia: an experience of 151 cases
Am J Obstet Gynecol
(2004) - et al.
Postpartum hypertension and nonsteroidal analgesia
Am J Obstet Gynecol
(2004) - et al.
Hypertension in the puerperium
Lancet
(1987) - et al.
The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery
Am J Obstet Gynecol
(1994)
The importance of urinary protein excretion during conservative management of severe preeclampsia
Am J Obstet Gynecol
Prognosis for preeclampsia complicated by 5 g or more proteinuria in 24 hours
Eur J Obstet Gynecol Reprod Biol
Epidemiology of eclampsia in Columbia
Int J Gynaecol Obstet
Preeclampsia into eclampsia: toward a new paradigm
Am J Obstet Gynecol
Eclampsia VIII; risk factors for maternal morbidity
Am J Obstet Gynecol
Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child
Am J Obstet Gynecol
Chronic hypertension in pregnancy
Obstet Gynecol
Thyroid and other endocrine disorders in pregnancy
Obstet Gynaecol Reprod Med
Primary aldosteronism as a cause of severe postpartum hypertension in two women
Am J Obstet Gynecol
Peripartum hypertension from pheochromocytoma: a rare and challenging entity
Am J Hypertens
Diagnosis and management of women with stroke during pregnancy–postpartum
Clin Perinatol
Imitators of severe pre-eclampsia
Semin Perinatol
Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006
Am J Obstet Gynecol
A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy
Am J Obstet Gynecol
Antihypertensive drugs in pregnancy
Semin Nephrol
Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome
Am J Obstet Gynecol
Cited by (208)
A randomized controlled trial comparing the efficacy of nifedipine and enalapril in the postpartum period
2023, American Journal of Obstetrics and Gynecology MFMIs magnesium sulfate therapy warranted in all cases of late postpartum severe hypertension? A suggested approach to a clinical conundrum
2023, American Journal of Obstetrics and GynecologyEmerging concepts since the Chronic Hypertension and Pregnancy trial
2023, American Journal of Obstetrics and GynecologyCare plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up
2023, American Journal of Obstetrics and GynecologyEffectiveness of extended postpartum inpatient monitoring for hypertensive disorders of pregnancy to reduce the risk of readmission for preeclampsia with severe features
2023, American Journal of Obstetrics and Gynecology MFM
The author reports no conflict of interest.
Reprints not available from the author.